EuroPCR 2026

19 May 2026

CTO Stents, scaffolds and DCB Other coronary interventions

The metal-free strategy: shaping the new era of hybrid vessel restoration with DCB and BRS

Sponsored by B. Braun

Anchorperson: G. Leibundgut

Spokesperson: M. Lutz

SHOW MORE

Summary

This EuroPCR 2026 session explores the emerging metal-free strategy in coronary intervention, combining drug-coated balloons (DCB) and bioresorbable scaffolds (BRS) to support a “leave-nothing-behind” approach to vessel restoration.

It focuses on lesion preparation, scaffold sizing and deployment, and the integration of hybrid therapies to optimise procedural outcomes. The discussion also highlights scaffold resorption, vessel remodelling and functional recovery as key elements for guiding decision-making in daily practice.

Complex lesions, including CTOs, are addressed through a simplified treatment concept, with key criteria helping to define good and poor candidates for DCB use in this setting.

Overall, the session highlights how DCB and BRS may work in a complementary way to enable more tailored and evolving strategies in coronary intervention.

Learning Objectives

To learn how to prepare lesions, size and deploy BRS appropriately, and integrate DCB effectively to achieve predictable procedural and clinical outcomes
To interpret scaffold resorption patterns, vessel remodelling, and functional restoration to support evidence-based decision making in daily practice
To explore how the complementary properties of the two modalities can support tailored therapy across different lesion subsets
To apply a simplified treatment concept for complex lesions, including CTO, using a leave-nothing-behind approach
To explore future perspectives in vessel restoration and the evolution of metal-free coronary intervention

Speaker

Innovations and insights on Fantom Encore BRS

Download presentation

Speaker

A practical guide to simplify treatment of CTO lesions

Download presentation